Jackson Laboratory Researchers Identify Neuromuscular Degeneration Gene

December 22, 1998

BAR HARBOR -- Scientists at The Jackson Laboratory have cloned the gene for the mouse mutation known as neuromuscular degeneration, or nmd, an advance that could boost research into such devastating neurological diseases in humans as amyotrophic lateral sclerosis and spinal muscular atrophy.

The results are published in a research paper, "Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele," in the December 1998 issue of the scientific journal Neuron. The Jackson Laboratory team was led by Dr. Gregory A. Cox, Dr. Wayne N. Frankel, and Connie L. Mahaffey.

"There are no effective treatments for these diseases, and the underlying causes of neurodegeneration remain obscure," said Dr. Cox, a Research Scientist in Dr. Frankel's group. "Mouse models of human disease like nmd provide unique tools for both gene discovery and analysis of underlying disease mechanisms. Our findings provide an additional tool for understanding the complex process of motor neuron death."

The nmd mouse was originally discovered at The Jackson Laboratory and reported in Mammalian Genome (March 1995) by researchers Susan A. Cook and Drs. Kenneth R. Johnson, Roderick T. Bronson, and Muriel T. Davisson. The mutation causes severe muscle atrophy due to progressive degeneration of spinal motor neurons, which control the movement of voluntary muscles. The mice exhibit progressive paralysis that initially begins with the hindlimbs. Variable forelimb paralysis occurs in later stages of the disease, with life expectancy rarely exceeding four weeks.

Similar motor neuron degeneration is implicated in amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). ALS, or "Lou Gehrig's Disease," is a fatal neurological disorder that attacks motor cells in the spinal cord and brain. The disease affects up to 30,000 people in the United States. About 5-10% of ALS cases are classified as familial and are suspected of having a genetic defect in a specific chromosome.

Spinal muscular atrophy, also characterized by degeneration of motor cells in the spinal cord and brain, is the second most common neuromuscular disorder of childhood, after Duchenne Muscular Dystrophy. SMA has three major childhood forms classified by age of onset. Most forms are genetic, and at least one gene involved in SMA has been identified to human chromosome 5q.

The Neuron paper reports that the defective gene in nmd mice, known as Smbp2, encodes a DNA-binding protein on chromosome 19. Although this protein has been studied previously by different laboratories as SMBP2 (immunoglobulin S-mu binding protein-2), GF1 (glial factor 1), RIP1 (rat insulin enhancer binding protein 1), or Catf1 (cardiac transcription factor 1), the new findings are the first indication of an essential role for the protein in motor neuron function and survival.

Proteins in the DNA helicase/ATPase family to which SMBP2 belongs are known to be involved in many cellular activities, including DNA replication, repair, and recombination. The gene encoding SMBP2 is widely expressed, with high levels in brain, heart, kidney, spleen, and testes, and lower levels in pancreas, liver, lung, and salivary gland. The human homolog of this gene is known to map to chromosome 11q, although it does not appear to be a major locus for familial ALS patients.

In another significant finding, the researchers report that severity of the nmd phenotype is suppressed by a modifier gene mapped to a locus (Mnm) on mouse Chromosome 13. The existence of such modifier genes has long been suspected in human ALS and SMA because of observed heterogeneity in age of onset and/or severity of symptoms.

The Mnm locus is in a mouse chromosomal region that shares homology with four different human regions containing many potential candidate genes, according to Dr. Cox. In addition, one potentially interesting mouse mutation that maps near Mnm is the progressive motor neuropathy (pmn) gene. The pmn phenotype is similar to that of nmd.

"The selective degeneration of motor neurons in this model and the dramatic effect that the single Mnm modifier gene has on the onset and progression of disease in the nmd mouse suggests that targets for intervention in motor neuron disease exist that can be manipulated to alter disease progression," Dr. Cox said.

The research at The Jackson Laboratory was supported in part by grants to Dr. Cox from the National Institutes of Health and the Amyotrophic Lateral Sclerosis Association, and to Dr. Frankel from the National Institutes of Health and the Klingenstein Fellowship in the Neurosciences.
-end-


Jackson Laboratory

Related Spinal Cord Articles from Brightsurf:

Stem cells can help repair spinal cord after injury
Spinal cord injury often leads to permanent functional impairment. In a new study published in the journal Science researchers at Karolinska Institutet in Sweden show that it is possible to stimulate stem cells in the mouse spinal cord to form large amounts of new oligodendrocytes, cells that are essential to the ability of neurons to transmit signals, and thus to help repair the spinal cord after injury.

Improving treatment of spinal cord injuries
A group led by UC Riverside bioengineering professor Victor G.

Spinal cord gives bio-bots walking rhythm
Miniature biological robots are making greater strides than ever, thanks to the spinal cord directing their steps.

Co-delivery of IL-10 and NT-3 to enhance spinal cord injury repair
Spinal cord injury (SCI) creates a complex microenvironment that is not conducive to repair; growth factors are in short supply, whereas factors that inhibit regeneration are plentiful.

Locomotor engine in the spinal cord revealed
Researchers at Karolinska Institutet in Sweden have revealed a new principle of organization which explains how locomotion is coordinated in vertebrates akin to an engine with three gears.

Neurological signals from the spinal cord surprise scientists
With a study of the network between nerve and muscle cells in turtles, researchers from the University of Copenhagen have gained new insight into the way in which movements are generated and maintained.

An 'EpiPen' for spinal cord injuries
An injection of nanoparticles can prevent the body's immune system from overreacting to trauma, potentially preventing some spinal cord injuries from resulting in paralysis.

From spinal cord injury to recovery
Spinal cord injury disconnects communication between the brain and the spinal cord, disrupting control over part of the body.

Transplanting adult spinal cord tissues: A new strategy of repair spinal cord injury
Spinal cord injury repair is one of the most challenging medical problems, and no effective therapeutic methods has been developed.

Gene medication to help treat spinal cord injuries
The two-gene medication has been proven to recover motor functions in rats.

Read More: Spinal Cord News and Spinal Cord Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.